First reported clinical evaluation of an allogeneic CD19-directed CAR T-cell therapy in progressive MS demonstrated an ...

Results presented at ESMO show a promising therapeutic index for [212Pb]VMT-α-NETDurable disease control in all three cohorts and 72% PFS at 18 months across all patients who received at least one ...

That timing and quick game approach has kept Mensah clean. Miami has been pressured on just 24.6% of drop-backs (24th ...

Notre Dame's Jonaz Walton has had an immediate impact with the team so far. His efforts led to him having a high PFF College true freshman grade.

Buffalo spent its bye with a one-game lead in the AFC East and a pass defense that has given up more yards than any in the ...

Immatics N.V. announced updated Phase 1 data for its IMA203CD8 PRAME TCR T-cell therapy across multiple solid tumor types. As of the August 7, 2026 data cutoff, 98 heavily pretreated patients across ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today shared the first data from a global Phase 1b clinical trial evaluating zocilurtatug pelitecan (zoci, ...

In the Breakfree-2 study, the majority of adverse events were brief and reversible, generally consistent with previously reported zola-cel Phase 1 clinical trial data.

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced updated clinical results that show promising anti-tumor activity and preliminary ...

PAS-004 achieved prolonged stable disease in a heavily pre-treated population, with four patients on PAS-004 for ...

Pasithea Therapeutics Corp. announced updated safety, tolerability, and preliminary efficacy data from its ongoing Phase 1 dose-escalation study of PAS-004 monotherapy in a heavily pre-treated ...